Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Mise à jour : Il y a 4 ans
Référence : NCT00692172

Femme et Homme

Extrait

An extension study to evaluate safety and tolerability of up to 3 additional courses of IM alefacept in patients with chronic plaque psoriasis who have been previously treated with 1 or 2 courses of IM alefacept.


Critère d'inclusion

  • Psoriasis


Liens